Therapeutic Potential of RNAi in Metabolic Diseases | Zendy

Cristina M. Rondi | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Therapeutic Potential of RNAi in Metabolic Diseases

Author(s) -

Cristina M. Rondi

Publication year - 2006

Publication title -

biotechniques

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.617

H-Index - 131

eISSN - 1940-9818

pISSN - 0736-6205

DOI - 10.2144/000112163

Subject(s) - rna interference , biology , computational biology , bioinformatics , gene , gene silencing , genetics , rna

Over the past years RNA interference (RNAi) has exploded as a new approach to manipulate gene expression in mammalian systems. More recently, RNAi has acquired interest as a potential therapeutic strategy. This review focuses on the potential therapeutic use of RNAi for metabolic diseases, the current understanding of RNAi biology, and how RNAi has been utilized to study the role of different genes in the pathogenesis of diabetes and obesity. Also reviewed are the in vivo proof-of-principle experiments that provide the preclinical justification for the development of RNAi-based therapeutics for diabetes and the key challenges that currently limit its application in the clinical setting.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research